Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Center Randomized Controlled Phase II Trial of Exercise to Treat Chemotherapy-Induced Peripheral Neuropathy (CIPN)

NCT04888988 is registered in ClinicalTrials.gov with University of Rochester NCORP Research Base as lead sponsor.

NCT NCT04888988
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04888988 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Center Randomized Controlled Phase II Trial of Exercise to Treat Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Lead sponsor
University of Rochester NCORP Research Base
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 25, 2022
Completion date
January 31, 2027
Enrollment
133 (actual)
Sites
93

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced peripheral neuropathy, hematopoietic and lymphoid cell neoplasm, malignant solid neoplasm